NCT04104672
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04104672
Title A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies (ARC-8)
Acronym ARC-8
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Los Angeles California 90025 United States Details
Research Site Santa Monica California 90404 United States Details
Research Site St Louis Missouri 63110 United States Details
Research Site New York New York 10016 United States Details
Research Site New York New York 10032 United States Details
Research Site New York New York 10065 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
Research Site Pittsburgh Pennsylvania 15232 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
Research Site San Antonio Texas 78229 United States Details
Research Site Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field